Which effect is caused by stimulation of alpha-1 receptors rather than alpha-2 receptors?
Choose an answer, then check it.
Clinical Pharmacology · Adrenergic Agonists
Alpha-Adrenergic Agonists
On this page 6 sections
In 30 seconds
Alpha adrenergic agonists stimulate alpha receptors of the sympathetic nervous system, but two very different clinical stories come from that one fact. Alpha-1 agonists like phenylephrine constrict blood vessels and tissue, raising blood pressure and shrinking swollen mucosa — useful for decongestion, ophthalmic dilation, and bladder-neck tightening. Alpha-2 agonists like clonidine act centrally to turn sympathetic outflow down, lowering blood pressure and producing sedation. Knowing the receptor subtype a drug targets predicts both its use and its signature adverse effect.
The college version
Two receptors, two directions
Alpha adrenergic agonists activate alpha-adrenergic receptors, part of the sympathetic "fight or flight" system. The class splits along receptor subtype, and the subtype largely determines what the drug does.
Alpha-1 receptors sit postsynaptically on smooth muscle: blood vessel walls, the iris dilator muscle, the bladder neck and prostatic capsule, and nasal mucosal vessels. Activating them contracts that smooth muscle. In vessels, this means vasoconstriction and higher blood pressure. In the eye, it means pupil dilation (mydriasis) without affecting near-focus ability. In the bladder neck and prostate, it increases outlet tone. In nasal tissue, it shrinks swollen mucosa.
Alpha-2 receptors work differently. Presynaptically, they act as negative feedback on sympathetic nerve terminals, telling them to release less norepinephrine. In the brainstem's vasomotor centers, alpha-2 agonists that cross into the brain reduce outgoing sympathetic drive itself. The net centrally-mediated effect is lower heart rate, lower blood pressure, and sedation — the opposite cardiovascular direction from alpha-1 stimulation, even though both are "alpha agonists."
Alpha-1 selective agonists
Phenylephrine is the prototype peripheral alpha-1 agonist. Given systemically, it raises blood pressure through vasoconstriction and treats hypotension during anesthesia or septic shock when a pure vasoconstrictor without direct cardiac stimulation is desired. Applied topically, it decongests nasal and ocular mucosa and dilates the pupil for eye exams. Because it raises blood pressure without stimulating the heart, it commonly triggers reflex bradycardia: baroreceptors sense the rising pressure and the vagus nerve slows the heart in compensation. Overused topical nasal decongestants also cause rebound congestion (rhinitis medicamentosa), where mucosal vessels become dependent on the drug and swell worse once it is stopped.
Midodrine is an oral alpha-1 agonist for chronic orthostatic hypotension, raising standing blood pressure by constricting arterial and venous beds. Its adverse effects mirror its mechanism: supine hypertension, worst when lying flat, so it is dosed only during waking hours, plus scalp tingling and piloerection ("goosebumps").
Central alpha-2 agonists
Clonidine is the prototype central alpha-2 agonist, used for hypertension and for opioid or alcohol withdrawal symptom control. By reducing central sympathetic outflow, it lowers heart rate and blood pressure and causes sedation and dry mouth as predictable class effects. Its most important adverse effect is rebound hypertension: abrupt discontinuation can trigger a sympathetic surge — high blood pressure, tachycardia, anxiety — because receptors have upregulated to compensate for chronic suppression. Clonidine must be tapered, never stopped abruptly.
Methyldopa is an older central alpha-2 agonist with a long safety record in pregnancy-associated hypertension. Converted centrally to an active metabolite, it stimulates central alpha-2 receptors much like clonidine, with the same sedation and dry mouth.
Dexmedetomidine is a highly selective alpha-2 agonist given intravenously for sedation in critical care and procedural settings. It produces a distinctive "cooperative sedation" — calm but arousable — with less respiratory depression than many sedatives, though it still carries the class risks of bradycardia and hypotension.
Tizanidine is a central alpha-2 agonist used as a skeletal muscle relaxant for spasticity. Its spinal alpha-2 action reduces excitatory input to motor neurons, easing spasm, but it shares the class's sedation, dry mouth, and hypotension.
Nursing considerations
For alpha-1 agents, monitor blood pressure and heart rate for reflex bradycardia and watch intravenous vasoconstrictor sites for extravasation, which can cause local tissue ischemia. For alpha-2 agents, monitor for sedation and hypotension, counsel patients never to stop clonidine-type drugs abruptly, and anticipate dry mouth as a near-universal complaint. Combining alpha-2 agonists with other central nervous system depressants intensifies sedation.
Eli explains
The same idea, in plain words
Explain it like I’m 10
Imagine a water hose (your blood vessel) and a ship's captain (your brain deciding how excited your body should be). Alpha-1 drugs squeeze the hose tighter — that pushes pressure up, and in your nose it squeezes swollen tissue so you can breathe again. Alpha-2 drugs are different: they whisper to the captain, "relax, slow down," so fewer "get excited" signals go out to the whole body. That drops heart rate and blood pressure and makes you sleepy. The tricky part with "calm the captain" drugs is that if you suddenly stop them, the captain — used to being told to relax — panics and shouts "GO GO GO" all at once, and blood pressure spikes hard. That's why you taper off slowly instead of quitting cold.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A patient uses an over-the-counter nasal decongestant spray nightly for three weeks and reports congestion now worse than before starting, even between doses. What is happening, and what class of drug caused it?
Show answer
Rebound congestion (rhinitis medicamentosa) from an overused topical alpha-1 decongestant
The nasal vessels adapted to constant squeezing by the spray's alpha-1 agonist, so once each dose wears off they swell up worse than the original congestion, pushing the patient toward using it again and again.
Why does an intravenous phenylephrine infusion for hypotension often cause the patient's heart rate to drop, even though phenylephrine does not act directly on the heart?
Show answer
A baroreceptor reflex through the vagus nerve slows the heart in response to rising pressure
Phenylephrine squeezes vessels and raises blood pressure directly, and baroreceptors sensing that higher pressure signal the vagus nerve to slow the heart as compensation, even though the drug itself never touches cardiac receptors.
Quick check
3 questions here. Answers stay hidden until you check.
A patient who has taken clonidine daily for two years abruptly stops it and returns two days later with a blood pressure of 210/120 mmHg and a racing heart. What is the most likely explanation?
Choose an answer, then check it.
Which drug is an oral alpha-1 agonist used for chronic orthostatic hypotension, dosed only during waking hours to avoid supine hypertension?
Choose an answer, then check it.
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.